cant believe people are worried about another CR for a company who literally just did one and now have 20mil in the bank.. Vaccines are good for another few years (not to mention they will most likely have a partner to pay most of the next stages), so we have 20m for the cardiocel side of things.
Thats heaps.
Id say we are good for a couple years, which by that time SP could be north of 30c+ being conservative..
By that time we could have 100+ centres on board AND more cardiocel applications ready for instant revenue, because once you have the centres in your pocket, its as easy as, 'hey try this out for hernia operations' Your not trying to sell products to new customers, which we are atm and doing one hell of a job at it.
I personally dont think we will need another CR as revenue should grow nicely from here, closing the capital vs cashburn numbers. Hell a CR at 25c will raise 5m for just 20m more shares, which is really nothing in the grand sceme of things.
its as if people are worried about a CR at these SP levels lol.
cant believe people are worried about another CR for a company...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |